This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Natus Medical Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

US$0

Verschuldung

Zinsdeckungsgrad	24x
Bargeld	US$84.29m
Eigenkapital	US$430.89m
Gesamtverbindlichkeiten	US$137.19m
Gesamtvermögen	US$568.08m

Jüngste Berichte zur Finanzlage

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Aug 02

Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Feb 15

Recent updates

Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600

Jul 22

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Mar 04

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Nov 08

We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Aug 13

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Aug 02

We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

Jun 10

Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Dec 07

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NTUS's short term assets ($286.8M) exceed its short term liabilities ($112.9M).

Langfristige Verbindlichkeiten: NTUS's short term assets ($286.8M) exceed its long term liabilities ($24.3M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NTUS is debt free.

Schulden abbauen: NTUS has no debt compared to 5 years ago when its debt to equity ratio was 35.5%.

Schuldendeckung: NTUS has no debt, therefore it does not need to be covered by operating cash flow.

Zinsdeckung: NTUS has no debt, therefore coverage of interest payments is not a concern.

This company has been acquired

Natus Medical Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

Recent updates

Natus Medical Incorporated(NasdaqGS:NTUS) dropped from NASDAQ Composite Index

Med Platform II, a fund managed by ArchiMed SAS completed the acquisition of Natus Medical Incorporated (NasdaqGS:NTUS) from a group of shareholders.

Novanta to replace Six Flags Entertainment in S&P MidCap 400, Six Flags to replace Natus Medical in S&P SmallCap 600

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

ArchiMed SAS has entered into a definitive agreement to acquire Natus Medical Incorporated (NasdaqGS:NTUS) for $1.2 billion.

Natus Medical Incorporated to Report Q1, 2022 Results on May 05, 2022

High number of new directors

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Full year 2021 earnings: EPS misses analyst expectations

Natus Medical Incorporated Provides Earnings Guidance for the Year 2022

Investor sentiment improved over the past week

Natus Medical Incorporated Reports Impairment Charges for the Fourth Quarter Ended December 31, 2021

Natus Medical Incorporated Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year 2021

VP of Quality notifies of intention to sell stock

Some Investors May Be Worried About Natus Medical's (NASDAQ:NTUS) Returns On Capital

Third quarter 2021 earnings released: EPS US$0.17 (vs US$0.28 loss in 3Q 2020)

High number of new directors

We Like Natus Medical's (NASDAQ:NTUS) Earnings For More Than Just Statutory Profit

Second quarter 2021 earnings released: EPS US$0.10 (vs US$0.26 loss in 2Q 2020)

Natus Medical Incorporated Provides Earnings Guidance for the Third Quarter and Full Year Fiscal 202

Does Natus Medical (NASDAQ:NTUS) Have A Healthy Balance Sheet?

Independent Chairperson Barbara Paul has left the company

Natus Medical Incorporated(NasdaqGS:NTUS) dropped from Russell 2000 Growth-Defensive Index

Independent Director recently sold US$81k worth of stock

We Think Shareholders Are Less Likely To Approve A Pay Rise For Natus Medical Incorporated's (NASDAQ:NTUS) CEO For Now

VP of Quality notifies of intention to sell stock

VP of Quality recently sold US$1.7m worth of stock

First quarter 2021 earnings released: EPS US$0.071 (vs US$0.11 loss in 1Q 2020)

Natus Medical Incorporated Provides Revenue Guidance for the Second Quarter and Year Ending 2021

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Full year 2020 earnings released: US$0.49 loss per share (vs US$0.47 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Is Natus Medical (NASDAQ:NTUS) Using Debt Sensibly?

New 90-day high: US$27.25

Breakeven Is Near for Natus Medical Incorporated (NASDAQ:NTUS)

Natus Medical Incorporated Revises Earnings Guidance for the Fourth Quarter 2020

New 90-day high: US$22.92

Natus Medical Incorporated to Report Q4, 2020 Results on Feb 25, 2021

Reflecting on Natus Medical's (NASDAQ:NTUS) Share Price Returns Over The Last Five Years

Natus Medical Incorporated (NasdaqGS:NTUS) acquired Babybe GmbH.

Third quarter 2020 earnings released: US$0.28 loss per share

Revenue and earnings beat expectations

New 90-day high: US$18.95

Revenue and earnings beat expectations

Third quarter 2020 earnings released: US$0.28 loss per share

Natus Medical Incorporated to Report Q3, 2020 Results on Oct 29, 2020

Natus Medical Incorporated Does Not Provide Earnings Guidance for the Year 2020

First half earnings released

New 90-day low - US$18.62

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen